Big Bird Foods Limited (BBFL) announced on Tuesday that it had successfully commissioned a 3-megawatt (MW) solar power system ...
More than 100 people have been arrested in the first three weeks of a trial of police and protective services officers ...
This news report details the detention of Ghulam Nabi Azad, son of suspended Trinamool Congress (TMC) MLA Humayun Kabir, by ...
Lester B. Pearson Catholic High School brought a modern twist to Shakespeare’s iconic works with their vivacious production ...
An official from the Indonesia Energy and Mineral Resources Ministry told us on Tuesday that the Ministry had signed a decree ...
The holiday season is notorious for its bustling airport terminals. With millions of travelers anticipated at Pearson, it’s crucial to plan your visit accordingly. According to airport spokesperson ...
Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1 ...
From religious hymns to classic covers by some of the commonwealth’s best known musicians, PA Local’s holiday playlist spans ...
Pharmaceutical Technology on MSN
Takeda to seek approval of plaque psoriasis pill on Phase III trial data
Takeda’s once-daily oral plaque psoriasis (PsO) drug has met all its endpoints in two pivotal trials, with the company set to seek approval from the US Food and Drug Administration (FDA) in 2026. In ...
Takeda’s zasocitinib landmark phase 3 plaque psoriasis data show promise to deliver clear skin in a once-daily pill, catalyzing a new era of treatment: Osaka, Japan Friday, Dece ...
Company and built by Sri Lanka Navy Petroleum Terminals Ltd Former Managing Director Ceylon Petroleum Corporation Former High Commissioner to Pakistan When the 1132nd RO plant built by the Navy with ...
Takeda reports positive Phase 3 data for psoriasis drug zasocitinib, beating placebo and Otezla, with rapid PASI responses and FDA filing plans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results